(1 - 26 from 28
)
Allergan aims to widen migraine treatment with MAP Pharma buy |...
www.reuters.com
U.S. specialty drugmaker Allergan Inc said late on Tuesday that it would buy MAP Pharmaceuticals Inc for about $958 million in cash, an acquisition intended to...
Allergan to Buy MAP Pharmaceuticals for $958 Million - The New York...
dealbook.nytimes.com
Allergan is buying a rival to gain control of its treatment for migraine headaches, which it believes the Food and Drug Administration will approve this spring.
Allergan To Acquire MAP Pharmaceuticals - Contract Pharma
www.contractpharma.com
Gains neurology therapies in $958 million deal
Allergan To Acquire MAP Pharmaceuticals In $958 Mln Deal
www.rttnews.com
Multi-specialty health-care company Allergan, Inc. (AGN) agreed Tuesday to acquire biopharmaceutical company MAP Pharmaceuticals, Inc.
sorted by relevance / date